Comparison of ciclesonide once daily (80 μg/d, 160 μg/d) and fluticasone propionate twice daily (176 μg/d) in the treatment of children with persistent asthma

S. Pedersen, A. A. Cruz, J. Fiterman, L. Barkai, S. Hirsch, R. Engelstätter (Kolding, Denmark; Salvador, Porto Alegre, Brazil; Miskolc, Hungary; Konstanz, Germany)

Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session: Anti-inflammatory therapy for childhood asthma
Session type: Electronic Poster Discussion
Number: 2700
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pedersen, A. A. Cruz, J. Fiterman, L. Barkai, S. Hirsch, R. Engelstätter (Kolding, Denmark; Salvador, Porto Alegre, Brazil; Miskolc, Hungary; Konstanz, Germany). Comparison of ciclesonide once daily (80 μg/d, 160 μg/d) and fluticasone propionate twice daily (176 μg/d) in the treatment of children with persistent asthma. Eur Respir J 2007; 30: Suppl. 51, 2700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ciclesonide 80 μg or 160 μg once daily is comparable to fluticasone propionate 88 μg twice daily in the treatment of asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 255s
Year: 2005

Ciclesonide once daily (80 mg/d, 160 mg/d) versus fluticasone propionate twice daily (250 mg/d) in the treatment of patients with persistent asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010

Comparison of ciclesonide (MDI) once daily and fluticasone propionate (Diskus®) twice daily in the treatment of patients with moderate asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 666s
Year: 2006

Once daily ciclesonide (80 µg or 320 µg) is equally effective as budesonide 200 µg given twice daily: a 12-week study in asthma patients
Source: Eur Respir J 2003; 22: Suppl. 45, 410s
Year: 2003

Ciclesonide 160 μg once daily compared with fluticasone propionate 250 μg twice daily in maintenance therapy of patients with stable asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 205s
Year: 2006

Comparison of 800 μg once vs. 400 μg twice daily inhaled budesonide in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 49s
Year: 2001

Comparable efficacy of ciclesonide 160 μg once daily and budesonide 200 μg twice daily in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Low-dose (100 μg, b.i.d.) inhaled fluticasone propionate (FP) is as effective as high-dose (500 μg, b.i.d.) in mild symptomatic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 96s
Year: 2001

"Stepping down" in mild-to-moderate asthmatic children, being well controlled while receiving low doses of inhaled corticosteroids (ICS): nedocromil sodium (NS) vs. fluticasone propionate (FP) 100 mcg/day given either twice
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Inhaled budesonide 800 μg once daily versus 400 μg twice daily in patients with mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 97s
Year: 2001

Comparison of once-daily ciclesonide 160 μg versus twice-daily fluticasone propionate 88 μg in children with moderate to severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 711s
Year: 2006

Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 346s
Year: 2004

12 weeks comparing salmeterol/fluticasone proprionate (SFC, 50/100 microg b.d. diskus) versus fluticasone proprionate (FP, 250 microg b.i.diskus) as first-line regular asthma treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 236s
Year: 2003

Salmeterol/fluticasone propionate combination (SFC) versus doubling dose of fluticasone propionate (FP) in children with asthma insufficiently controlled on moderate doses of inhaled corticosteroids
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012

The effect of two month's treatment with fluticasone (F) at a dose of 500 mg per day versus fluticasone at a dose of 250 mg per day plus salmeterol (S) 100 mg per day in patients with moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 302s
Year: 2002

Variability in asthma and treatment efficacy as determined by weekly response rates with fluticasone propionate/salmeterol 100/50mcg (FSC) compared with montelukast 10mg (MON)
Source: Eur Respir J 2003; 22: Suppl. 45, 259s
Year: 2003

Evaluation of long-term safety, growth and efficacy of fluticasone propionate 100mcg bd compared with sodium cromoglycate 5mg qds in asthmatic children aged 12-47 months
Source: Eur Respir J 2002; 20: Suppl. 38, 219s
Year: 2002

The effects of fluticasone propionate/salmeterole 50/100 μg bid in children with asthma versus beclometasone propionate 200 μg BD and fluticasone propionate 100 μg bid dry powder inhaletors
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004

Single dose of of tiotropium bromide (18 mcg) produces a similar bronchodilator response as two doses of formoterol fumarate (12 mcg ) over 24 hours in subjects with moderate-to-severe asthma
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010